These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 2004595)

  • 1. On the mechanisms for the selective action of vitamin D analogs.
    Dusso AS; Negrea L; Gunawardhana S; Lopez-Hilker S; Finch J; Mori T; Nishii Y; Slatopolsky E; Brown AJ
    Endocrinology; 1991 Apr; 128(4):1687-92. PubMed ID: 2004595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin D analogs with low affinity for the vitamin D binding protein: enhanced in vitro and decreased in vivo activity.
    Bouillon R; Allewaert K; Xiang DZ; Tan BK; van Baelen H
    J Bone Miner Res; 1991 Oct; 6(10):1051-7. PubMed ID: 1796753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Actions of vitamin D3, analogs on human prostate cancer cell lines: comparison with 1,25-dihydroxyvitamin D3.
    Skowronski RJ; Peehl DM; Feldman D
    Endocrinology; 1995 Jan; 136(1):20-6. PubMed ID: 7530193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The activity of 22-oxacalcitriol in osteoblast-like (ROS 17/2.8) cells.
    Pernalete N; Mori T; Nishii Y; Slatopolsky E; Brown AJ
    Endocrinology; 1991 Aug; 129(2):778-84. PubMed ID: 1649745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of 2-methylene-19-nor-(20S)-1 alpha-hydroxy-bishomopregnacalciferol (2MbisP), an analog of vitamin D, on secondary hyperparathyroidism.
    Slatopolsky E; Finch JL; Brown AJ; Ritter CS; Mizobuchi M; Plum LA; Clagett-Dame M; Sicinski RR; DeLuca HF
    J Bone Miner Res; 2007 May; 22(5):686-94. PubMed ID: 17444814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The noncalcemic analogue of vitamin D, 22-oxacalcitriol, suppresses parathyroid hormone synthesis and secretion.
    Brown AJ; Ritter CR; Finch JL; Morrissey J; Martin KJ; Murayama E; Nishii Y; Slatopolsky E
    J Clin Invest; 1989 Sep; 84(3):728-32. PubMed ID: 2760211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mechanism for the disparate actions of calcitriol and 22-oxacalcitriol in the intestine.
    Brown AJ; Finch J; Grieff M; Ritter C; Kubodera N; Nishii Y; Slatopolsky E
    Endocrinology; 1993 Sep; 133(3):1158-64. PubMed ID: 8396012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormal expression and regulation of vitamin D receptor in experimental uremia.
    Szabó A; Ritz E; Schmidt-Gayk H; Reichel H
    Nephron; 1996; 73(4):619-28. PubMed ID: 8856261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1,25(OH)2-16ene-vitamin D3 is a potent antileukemic agent with low potential to cause hypercalcemia.
    Jung SJ; Lee YY; Pakkala S; de Vos S; Elstner E; Norman AW; Green J; Uskokovic M; Koeffler HP
    Leuk Res; 1994 Jun; 18(6):453-63. PubMed ID: 8207963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective biological response by target organs (intestine, kidney, and bone) to 1,25-dihydroxyvitamin D3 and two analogues.
    Norman AW; Sergeev IN; Bishop JE; Okamura WH
    Cancer Res; 1993 Sep; 53(17):3935-42. PubMed ID: 8395333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo and in vitro effect of 1,25-dihydroxyvitamin D3 and 1,25-dihydroxy-16-ene-23-yne-vitamin D3 on the proliferation and differentiation of avian chondrocytes: their role in tibial dyschondroplasia.
    Farquharson C; Rennie JS; Loveridge N; Whitehead CC
    J Endocrinol; 1996 Mar; 148(3):465-74. PubMed ID: 8778225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biologic activity of dihydroxylated 19-nor-(pre)vitamin D3.
    Bouillon R; Sarandeses LA; Allewaert K; Zhao J; Mascareñas JL; Mouriño A; Vrielynck S; de Clercq P; Vandewalle M
    J Bone Miner Res; 1993 Aug; 8(8):1009-15. PubMed ID: 8213251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roles of the structure and orientation of ligands and ligand mimics inside the ligand-binding pocket of the vitamin D-binding protein.
    Swamy N; Dutta A; Ray R
    Biochemistry; 1997 Jun; 36(24):7432-6. PubMed ID: 9200691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of vitamin D analogs and of vitamin D-binding protein on lymphocyte proliferation.
    Vanham G; Van Baelen H; Tan BK; Bouillon R
    J Steroid Biochem; 1988 Apr; 29(4):381-6. PubMed ID: 3374126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of 19-nor-1,25(OH)2D2, a new analogue of calcitriol, on secondary hyperparathyroidism in uremic rats.
    Slatopolsky E; Finch J; Ritter C; Takahashi F
    Am J Kidney Dis; 1998 Oct; 32(2 Suppl 2):S40-7. PubMed ID: 9808142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new analog of 1,25-(OH)2D3, 19-NOR-1,25-(OH)2D2, suppresses serum PTH and parathyroid gland growth in uremic rats without elevation of intestinal vitamin D receptor content.
    Takahashi F; Finch JL; Denda M; Dusso AS; Brown AJ; Slatopolsky E
    Am J Kidney Dis; 1997 Jul; 30(1):105-12. PubMed ID: 9214408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parathyroid hormone suppression by 22-oxacalcitriol in the severe parathyroid hyperplasia.
    Funahashi H; Tanaka Y; Imai T; Wada M; Tsukamura K; Hayakawa Y; Matsuura N; Kikumori T; Oiwa M; Tominaga Y; Takagi H
    J Endocrinol Invest; 1998 Jan; 21(1):43-7. PubMed ID: 9633022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The binding properties, with blood proteins, and tissue distribution of 22-oxa-1 alpha,25-dihydroxyvitamin D3, a noncalcemic analogue of 1 alpha, 25-dihydroxyvitamin D3, in rats.
    Kobayashi T; Tsugawa N; Okano T; Masuda S; Takeuchi A; Kubodera N; Nishii Y
    J Biochem; 1994 Mar; 115(3):373-80. PubMed ID: 8056745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of PTH and decreased action on bone are partially responsible for the low calcemic activity of 22-oxacalcitriol relative to 1,25-(OH)2D3.
    Finch JL; Brown AJ; Mori T; Nishii Y; Slatopolsky E
    J Bone Miner Res; 1992 Jul; 7(7):835-9. PubMed ID: 1642151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.